WallStreetZenWallStreetZen

NASDAQ: ENTO
Entero Therapeutics Inc Stock Ownership - Who owns Entero Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Entero Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah RomanoChief Financial Officer2025-01-06727$0.64
$465.28Sell
Sarah RomanoChief Financial Officer2024-10-09476$0.45
$212.30Sell
Sarah RomanoChief Financial Officer2024-07-02621$1.07
$664.47Sell
James SapirsteinChairman and CEO2024-07-021,289$1.07
$1.38kSell

1 of 1

ENTO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENTO insiders and whales buy or sell their stock.

ENTO Shareholders

What type of owners hold Entero Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Edmund Burke Ross Jr.63.80%3,040,555$1.15MInsider
Pelican Partners LLC34.16%1,627,796$616.93kInsider
Johan M. Spoor8.78%418,319$158.54kInsider
Charles J. Casamento2.87%136,935$51.90kInsider
David Andrew Hoffman1.90%90,778$34.40kInsider
Vern Lee Schramm1.90%90,498$34.30kInsider
Maged Shenouda1.31%62,500$23.69kInsider
James Sapirstein0.75%35,816$13.57kInsider
Edward Borkowski0.71%33,928$12.86kInsider
Ground Swell Capital LLC0.55%26,231$9.94kInstitution

1 of 3

ENTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENTO1.26%98.74%Net Selling
PBM7.76%92.24%
PTIX27.89%8.52%
ADTX1.52%98.48%Net Selling
TNFA1.25%71.93%
View Top Biotech Stocks

Entero Therapeutics Stock Ownership FAQ

Who owns Entero Therapeutics?

Entero Therapeutics (NASDAQ: ENTO) is owned by 1.52% institutional shareholders, 118.59% Entero Therapeutics insiders, and 0.00% retail investors. Edmund Burke Ross Jr. is the largest individual Entero Therapeutics shareholder, owning 3.04M shares representing 63.80% of the company. Edmund Burke Ross Jr.'s Entero Therapeutics shares are currently valued at $1.21M.

If you're new to stock investing, here's how to buy Entero Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.